| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 352 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 341 |
| 2 | TACROLIMUS OINTMENT 0.1% | 341 |
| 3 | MYCOPHENOLATE MOFETIL | 293 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 293 |
| 5 | PREDNISONE | 278 |
| 6 | PREDNISOLONE | 209 |
| 7 | PREDNISOLONE ORAL | 209 |
| 8 | PREDNISOLONE ORAL SOLUTION | 209 |
| 9 | CYCLOPHOSPHAMIDE | 173 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COLLOIDAL OATMEAL 1% | 1 | 0.0714 |
| 1 | BENZNIDAZOLE | 5 | 0.0490 |
| 2 | ZOPAPOGENE IMADENOVEC | 1 | 0.0250 |
| 3 | SUTIMLIMAB-JOME | 4 | 0.0125 |
| 4 | TREOSULFAN | 31 | 0.0112 |
| 5 | CALCIPOTRIENE CREAM, 0.005% | 1 | 0.0097 |
| 6 | APRACLONIDINE | 1 | 0.0090 |
| 7 | BRINCIDOFOVIR | 1 | 0.0072 |
| 8 | CIDOFOVIR ANHYDROUS | 10 | 0.0069 |
| 9 | DAUNORUBICIN HYDROCHLORIDE | 9 | 0.0055 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Classical Complement Pathway Inhibitor [EPC] | 4 | 0.0125 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 5 | 0.0039 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 87 | 0.0039 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 67 | 0.0031 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 27 | 0.0020 |
| 5 | Macrolide Antibacterial [EPC] | 2 | 0.0020 |
| 6 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 6 | 0.0018 |
| 7 | Sulfonamide Antibacterial [EPC] | 7 | 0.0018 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 33 | 0.0017 |
| 9 | CD19-directed Chimeric Antigen Receptor [EPC] | 14 | 0.0014 |